Further studies are needed to elucidate the effects on muscle fatigue during strenuous exercise, neurological disorders, metabolic syndrome, atopic dermatitis, uraemic anaemia resistant to erythropoietin therapy, and inflammatory bowel diseases and as a supplement to increase the effectiveness of methotrexate in treatment of malignancies. This evidence concerns the gene EPO and metabolic syndrome.